Mucinex dominates the cough brand experience, Treato finds

NEW YORK - Treato on Tuesday released its first annual list of top over-the-counter cough medications. Reckitt Benckiser's Mucinex brands dominate the list with their formulations taking three of the top four spots. Mucinex D took the No. 1 spot, Mucinex took the third spot and Mucinex DM took the fourth spot on the list. 

 

Treato found that brand marketing plays a large role in consumers' experiences of cough medications as products with the same formulations placed in significantly different spots on the list. Reckitt Benckiser and Pfizer were the manufacturers to dominate the list taking all spots on the list except for one.

 

"Reckitt Benckiser's investment in DTC advertising is clearly paying off as consumers are disproportionately discussing their brands online," stated Ido Hadari, CEO of Treato. "We hope that by identifying and ranking over-the-counter cold medications based on other consumer's experiences we are able to help them navigate the drug store aisles when searching for cold relief."

 

TreatoVoice is a unique data asset that continuously collects and analyzes more than 2 billion patient and caregiver conversations happening across the Internet to understand what patients are saying about their experiences with their conditions and treatments. Within TreatoVoice, Treato has the capability to algorithmically identify and rank patients' experiences with medications within their Web posts. 

 

Treato Satisfaction scores are overall drug scores that are calculated based on a ratio of positive to negative reviews about a medication with weight given to the volume and recency of conversations happening online and Treato Concern scores are calculated based on the percentage of patient online conversations that raise a concern or discuss a side effect in the conversation compared to all of the conversations about the brand happening online.